| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT03606967 | Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| Phase 1 | |||
| NCT06529822 | Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular… | Muscle-Invasive Bladder Carcinoma | Recruiting |
| NCT05098210 | Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT06218303 | Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal… | Ductal Carcinoma in Situ | Recruiting |
| NCT04616248 | In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in… | Anatomic Stage IV Breast Cancer AJCC v8 | Active, Not Recruiting |
| NCT05010200 | The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the… | Prostate Cancer | Active, Not Recruiting |
| NCT06342908 | A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse… | Diffuse Hemispheric Glioma, H3 G34-Mutant | Active, Not Recruiting |
| NCT02886065 | A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM | Smoldering Multiple Myeloma | Active, Not Recruiting |
| NCT02287428 | Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly… | Glioblastoma | Active, Not Recruiting |
| NCT05283109 | ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM | Glioma, Malignant | Active, Not Recruiting |
| NCT07300475 | Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients | Triple Negative Breast Cancer | Not Yet Recruiting |